Clinical significance of p53, mdm2, and bcl-2 proteins in renal cell carcinoma.

Toyoaki Uchida; Jiang Ping Gao; Chunxi Wang; Shi Xu Jiang; Masatoshi Muramoto; Takefumi Satoh; Sadanori Minei; Satoru Shimura; Akira Irie; Toru Kameya

doi:10.1016/s0090-4295(01)01601-6

Clinical significance of p53, mdm2, and bcl-2 proteins in renal cell carcinoma.

Identifier:nobleid.org/w1/20260515/2CD97481

Type:Journal Article

0 views

Support unavailableClaim Your Authorship

View Original Paper Source

Embeddable Badge

[![NobleID](https://www.nobleid.org/api/badge/2CD97481.svg?ark=w1%2F20260515%2F2CD97481)](https://nobleid.org/work/w1/20260515/2CD97481)

ARK Inflections

Metadata Policy

Metadata Formats

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors

Claim authorship of this work

Clinical significance of p53, mdm2, and bcl-2 proteins in renal cell carcinoma.

Identifier:nobleid.org/w1/20260515/2CD97481

Type:Journal Article

0 views

Support unavailableClaim Your Authorship

View Original Paper Source

Embeddable Badge

[![NobleID](https://www.nobleid.org/api/badge/2CD97481.svg?ark=w1%2F20260515%2F2CD97481)](https://nobleid.org/work/w1/20260515/2CD97481)

ARK Inflections

Metadata Policy

Metadata Formats

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors

Claim authorship of this work